DOI QR코드

DOI QR Code

The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?

  • Yamasaki, Takahisa (The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University) ;
  • Hemond, Colin (Department of Physiology and Biophysics, Case Western Reserve University) ;
  • Eisa, Mohamed (Department of Internal Medicine, Case Western Reserve University, MetroHealth Medical Center) ;
  • Ganocy, Stephen (Center for Health Care Research and Policy, Case Western Reserve University, MetroHealth Medical Center) ;
  • Fass, Ronnie (The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University)
  • Received : 2018.08.07
  • Accepted : 2018.08.28
  • Published : 2018.10.30

Abstract

Background/Aims Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. Traditionally, GERD has been considered a disease of middle-aged and older people. Since risk factors for GERD affect a growing number of the adult population, concerns have been raised that increasingly younger people may develop GERD. We aim to determine if the proportion of younger patients has increased among the GERD population. Methods The incidence of GERD as well as several variables were evaluated during an 11-year period. Explorys was used to evaluate datasets at a "Universal" and Healthcare system in northern Ohio to determine if trends at a local level reflected those at a universal level. GERD patients were classified into 7 age groups (15-19, 20-29, 30-39, 40-49, 50-59, 60-69, and ${\geq}70$ years). Results The proportion of patients with GERD increased in all age groups, except for those who were ${\geq}70$ years in the universal dataset (P < 0.001) and those who were ${\geq}60$ years in the Healthcare system (P < 0.001). The greatest rise was seen in 30-39 years in both datasets (P < 0.001). Similarly, the proportion of GERD patients who were using proton pump inhibitors increased in all age groups except for those who were ${\geq}70$ years in both datasets (P < 0.001), with the greatest increase being the group 30-39 years (P < 0.001). Conclusion Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years.

Keywords

References

  1. Tack J, Becher A, Mulligan C, Johnson DA. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther 2012;35:1257-1266. https://doi.org/10.1111/j.1365-2036.2012.05086.x
  2. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014;63:871-880. https://doi.org/10.1136/gutjnl-2012-304269
  3. Mahadeva S, Raman MC, Ford AC, et al. Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia. Aliment Pharmacol Ther 2005;21:1483-1490. https://doi.org/10.1111/j.1365-2036.2005.02455.x
  4. Jarosz M, Taraszewska A. Risk factors for gastroesophageal reflux disease: the role of diet. Prz Gastroenterol 2014;9:297-301.
  5. Saberi-Firoozi M, Khademolhosseini F, Yousefi M, Mehrabani D, Zare N, Heydari ST. Risk factors of gastroesophageal reflux disease in Shiraz, southern Iran. World J Gastroenterol 2007;13:5486-5491. https://doi.org/10.3748/wjg.v13.i41.5486
  6. Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol 2007;5:1392-1398. https://doi.org/10.1016/j.cgh.2007.08.011
  7. Achem AC, Achem SR, Stark ME, DeVault KR. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol 2003;98:35-39. https://doi.org/10.1111/j.1572-0241.2003.07188.x
  8. Ter RB, Johnston BT, Castell DO. Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis Esophagus 1998;11:106-108. https://doi.org/10.1093/dote/11.2.106
  9. Becher A, Dent J. Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis. Aliment Pharmacol Ther 2011;33:442-454. https://doi.org/10.1111/j.1365-2036.2010.04542.x
  10. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018;67:430-440. https://doi.org/10.1136/gutjnl-2016-313589
  11. Thukkani N, Sonnenberg A. The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States. Aliment Pharmacol Ther 2010;31:852-861.
  12. Sonnenberg A, Massey BT, Jacobsen SJ. Hospital discharges resulting from esophagitis among Medicare beneficiaries. Dig Dis Sci 1994;39:183-188. https://doi.org/10.1007/BF02090080
  13. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004;126:660-664. https://doi.org/10.1053/j.gastro.2003.12.001
  14. Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut 2012;61:1390-1397. https://doi.org/10.1136/gutjnl-2011-300715
  15. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003;17:1309-1317. https://doi.org/10.1046/j.1365-2036.2003.01588.x
  16. Matsuura B, Nunoi H, Miyake T, Hiasa Y, Onji M. Obesity and gastrointestinal liver disorders in Japan. J Gastroenterol Hepatol 2013;28(suppl 4):48-53. https://doi.org/10.1111/jgh.12238
  17. Pilotto A, Franceschi M, Leandro G, et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 2006;54:1537-1542. https://doi.org/10.1111/j.1532-5415.2006.00899.x
  18. Maekawa T, Kinoshita Y, Okada A, et al. Relationship between severity and symptoms of reflux oesophagitis in elderly patients in Japan. J Gastroenterol Hepatol 1998;13:927-930. https://doi.org/10.1111/j.1440-1746.1998.tb00763.x
  19. Craven MR, Kia L, O'Dwyer LC, Stern E, Taft TH, Keefer L. Systematic review: methodological flaws in racial/ethnic reporting for gastroesophageal reflux disease. Dis Esophagus Published Online First: 1 Mar 2018. doi: 10.1093/dote/dox154.
  20. Hershcovici T, Fass R. Nonerosive reflux disease (NERD) - an update. J Neurogastroenterol Motil 2010;16:8-21. https://doi.org/10.5056/jnm.2010.16.1.8
  21. Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease--current concepts and dilemmas. Am J Gastroenterol 2001;96:303-314.
  22. Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology 2017;153:35-48. https://doi.org/10.1053/j.gastro.2017.04.047

Cited by

  1. Undetected Barrett’s esophagus: how do we improve early detection? vol.12, pp.24, 2018, https://doi.org/10.18632/oncotarget.28005
  2. Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease vol.2019, pp.None, 2018, https://doi.org/10.1155/2019/6415757
  3. Management of Gastroesophageal Reflux Disease in the Elderly Patient vol.36, pp.12, 2018, https://doi.org/10.1007/s40266-019-00708-2
  4. Magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: pros and cons vol.36, pp.4, 2018, https://doi.org/10.1097/mog.0000000000000643
  5. Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation vol.75, pp.None, 2020, https://doi.org/10.6061/clinics/2020/e1556
  6. Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study vol.11, pp.None, 2018, https://doi.org/10.3389/fphar.2020.00433
  7. 만성 역류성 식도염 동물 모델에 대한 황백(黃柏) 물 추출물의 식도 점막 보호 효과 vol.35, pp.4, 2020, https://doi.org/10.6116/kjh.2020.35.4.25.
  8. Application of mineral waters in the complex treatment of patients with gastroesophageal reflux disease vol.66, pp.3, 2018, https://doi.org/10.23736/s1121-421x.20.02601-x
  9. Food patterns in Russian patients with gastroesophageal reflux disease: the results of pilot comparative study vol.92, pp.8, 2018, https://doi.org/10.26442/00403660.2020.08.000760
  10. Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study vol.20, pp.None, 2018, https://doi.org/10.1186/s12876-020-01261-8
  11. Physicians’ adherence to management guidelines for H. pylori infection and gastroesophageal reflux disease: a cross-sectional study vol.9, pp.1, 2018, https://doi.org/10.1186/s13584-020-00389-y
  12. Treatment of Dyspepsia, Heartburn, and Related Symptoms with Gastricumeel Compared to Proton Pump Inhibitors: A Prospective Reference-Controlled Observational Study vol.28, pp.3, 2018, https://doi.org/10.1159/000511285
  13. Epidemiology and Outcomes of Young-Onset Esophageal Adenocarcinoma: An Analysis from a Population-Based Database vol.30, pp.1, 2021, https://doi.org/10.1158/1055-9965.epi-20-0944
  14. Prevalence and risk factors of gastroesophageal reflux disease in a rural Indian population vol.40, pp.1, 2018, https://doi.org/10.1007/s12664-020-01135-7
  15. A transformational change in scintigraphic gastroesophageal reflux studies: A comparison with historic techniques vol.41, pp.2, 2018, https://doi.org/10.1111/cpf.12677
  16. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: A meta-analysis and meta-regression study vol.40, pp.2, 2021, https://doi.org/10.1007/s12664-020-01104-0
  17. Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy? vol.14, pp.None, 2021, https://doi.org/10.1016/j.bonr.2021.101095
  18. Impact of chronic constipation on health‐related quality of life and work productivity in Japan vol.36, pp.6, 2021, https://doi.org/10.1111/jgh.15295